Provided herein are anti-CD5L monoclonal antibodies. Further provided herein are methods of use thereof for the treatment of a disease or disorder, such as cancer.
UTHealth Ref. No.: 2020-0016
Inventors: Dr. Zhiqiang An and Dr. Ningyan Zhang at UTHealth; Dr. Anil Sood at UT M.D. Anderson Cancer Center
Patent Status: PCT application PCT/US2021/025429 filed 4/1/2021; nationalized in US, CN, and EPO
License Available: world-wide, exclusive